Boehringer Ingelheim, Dicerna tema up to make treatments for chronic liver diseases
Boehringer Ingelheim and Dicerna Pharmaceuticals have announced a research collaboration and license agreement to discover and develop novel GalXC RNAi…
Pharmaceuticals, Biotechnology and Life Sciences
Boehringer Ingelheim and Dicerna Pharmaceuticals have announced a research collaboration and license agreement to discover and develop novel GalXC RNAi…
GlaxoSmithKline said on Thursday that its investigational BCMA antibody-drug has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration…
Sanofi’s Q3 2017 sales performance were supported by Sanofi Genzyme, Sanofi Pasteur and Emerging Markets, and it saw net sales…
Basilea Pharmaceutica said Thursday its licensing partner Pfizer recently launched the antifungal drug Cresemba (isavuconazole) in Spain. Pfizer is now commercializing…
TiGenix has further strengthened its IP protection around the company’s lead product Cx601, intended for the treatment of complex perianal fistulas…
Pharmapack Europe 2018 today announced the comprehensive event programme for Europe’s dedicated pharmaceutical packaging and drug delivery conference and exhibition…
Actelion said on Tuesday that, by decision dated October 25, 2017, the Cantonal Court of the Canton of Basel-Landschaft cancelled all…
Novartis said on Tuesday that it has submitted a supplemental Biologics License Application (sBLA) to the US Food and Drug…
Mereo BioPharma has made a deal with AstraZeneca for an exclusive license, including an option to acquire, AZD9668, an oral inhibitor…
Hemogenyx Pharmaceuticals has picked LakePharma as its service provider for the development and manufacturing of Hemogenyx’s lead product, CDX bi-specific…